 | • レポートコード：MRC2109A042 • 出版社/出版日：Transparency Market Research / 2021年6月30日 • レポート形態：英文、PDF、191ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートは、D2C実験室検査の世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、主要インサイト、検査別（遺伝子検査、疾病リスク分析検査、CBC、糖尿病検査、TSH検査、歯科用ハンドピース、その他）分析、サンプル別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しております。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・D2C実験室検査の世界市場規模：検査別（遺伝子検査、疾病リスク分析検査、CBC、糖尿病検査、TSH検査、歯科用ハンドピース、その他） ・D2C実験室検査の世界市場規模：サンプル別 ・D2C実験室検査の世界市場規模：エンドユーザー別 ・D2C実験室検査の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Direct-to-Consumer Laboratory Testing Market – Scope of Report
TMR’s report on the global direct-to-consumer laboratory testing market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global direct-to-consumer laboratory testing market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global direct-to-consumer laboratory testing market during the forecast period.
The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global direct-to-consumer laboratory testing market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global direct-to-consumer laboratory testing market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global direct-to-consumer laboratory testing market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global direct-to-consumer laboratory testing market.
The report delves into the competitive landscape of the global direct-to-consumer laboratory testing market. Key players operating in the global direct-to-consumer laboratory testing market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global direct-to-consumer laboratory testing market that have been profiled in this report.
Key Questions Answered in Direct-to-Consumer Laboratory Testing Market Report
What is the revenue forecast for the global direct-to-consumer laboratory testing market in terms of revenue for the period 2021–2031?
How would various dynamics such as drivers, restraints, opportunities, and trends impact the market?
What is the market size and estimation for the direct-to-consumer laboratory testing market across regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
Which regional market is poised to expand at a significant CAGR during the forecast period?
Which product segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?
Research Methodology
A unique methodology has been utilized by TMR to conduct comprehensive research on the growth of the global direct-to-consumer laboratory testing market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary research sources referred to by analysts during the production of the global direct-to-consumer laboratory testing market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the direct-to-consumer laboratory testing market as primary methods.
These primary research respondents have provided exclusive information during interviews, which serves as a validation from the direct-to-consumer laboratory testing market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global direct-to-consumer laboratory testing market with accuracy. The study also uses the top-down approach to assess the revenue of each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global direct-to-consumer laboratory testing market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Direct-to-Consumer Laboratory Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Disease Prevalence & Incidence Rate
5.3. Regulatory Scenario
5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
6.3.1. Genetic testing
6.3.2. Disease risk assessment testing
6.3.2.1. Cancer
6.3.2.2. STDs
6.3.2.3. Others
6.3.3. CBC
6.3.4. Diabetes testing
6.3.5. TSH testing
6.3.6. Others
6.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Test Type
7. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type , 2017–2031
7.3.1. Blood
7.3.2. Urine
7.3.3. Saliva
7.3.4. Others
7.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Sample Type
8. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Specialty labs
8.3.4. Diagnostic centres
8.4. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by End-user
9. Global Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Direct-to-Consumer Laboratory Testing Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Direct-to-Consumer Laboratory Testing Market Attractiveness, by Country/Region
10. North America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
10.2.1. Genetic testing
10.2.2. Disease risk assessment testing
10.2.2.1. Cancer
10.2.2.2. STDs
10.2.2.3. Others
10.2.3. CBC
10.2.4. Diabetes testing
10.2.5. TSH testing
10.2.6. Others
10.3. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031
10.3.1. Blood
10.3.2. Urine
10.3.3. Saliva
10.3.4. Others
10.4. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Specialty labs
10.4.4. Diagnostic centres
10.5. North America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Sample Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
11.2.1. Genetic testing
11.2.2. Disease risk assessment testing
11.2.2.1. Cancer
11.2.2.2. STDs
11.2.2.3. Others
11.2.3. CBC
11.2.4. Diabetes testing
11.2.5. TSH testing
11.2.6. Others
11.3. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031
11.3.1. Blood
11.3.2. Urine
11.3.3. Saliva
11.3.4. Others
11.4. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Specialty labs
11.4.4. Diagnostic centres
11.5. Europe Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Sample Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
12.2.1. Genetic testing
12.2.2. Disease risk assessment testing
12.2.2.1. Cancer
12.2.2.2. STDs
12.2.2.3. Others
12.2.3. CBC
12.2.4. Diabetes testing
12.2.5. TSH testing
12.2.6. Others
12.3. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031
12.3.1. Blood
12.3.2. Urine
12.3.3. Saliva
12.3.4. Others
12.4. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Specialty labs
12.4.4. Diagnostic centres
12.5. Asia Pacific Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Sample Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
13.2.1. Genetic testing
13.2.2. Disease risk assessment testing
13.2.2.1. Cancer
13.2.2.2. STDs
13.2.2.3. Others
13.2.3. CBC
13.2.4. Diabetes testing
13.2.5. TSH testing
13.2.6. Others
13.3. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031
13.3.1. Blood
13.3.2. Urine
13.3.3. Saliva
13.3.4. Others
13.4. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Specialty labs
13.4.4. Diagnostic centres
13.5. Latin America Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Sample Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Test Type, 2017–2031
14.2.1. Genetic testing
14.2.2. Disease risk assessment testing
14.2.2.1. Cancer
14.2.2.2. STDs
14.2.2.3. Others
14.2.3. CBC
14.2.4. Diabetes testing
14.2.5. TSH testing
14.2.6. Others
14.3. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Sample Type, 2017–2031
14.3.1. Blood
14.3.2. Urine
14.3.3. Saliva
14.3.4. Others
14.4. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Specialty labs
14.4.4. Diagnostic centers
14.5. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Sample Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Laboratory Corporation of America Holdings
15.1.1.1. Company Overview
15.1.1.2. Company Financials
15.1.1.3. Growth Strategies
15.1.1.4. SWOT Analysis
15.1.2. Quest Diagnostics Incorporated
15.1.2.1. Company Overview
15.1.2.2. Company Financials
15.1.2.3. Growth Strategies
15.1.2.4. SWOT Analysis
15.1.3. 23andMe, Inc.
15.1.3.1. Company Overview
15.1.3.2. Company Financials
15.1.3.3. Growth Strategies
15.1.3.4. SWOT Analysis
15.1.4. EverlyWell, Inc
15.1.4.1. Company Overview
15.1.4.2. Company Financials
15.1.4.3. Growth Strategies
15.1.4.4. SWOT Analysis
15.1.5. DirectLabs, LLC
15.1.5.1. Company Overview
15.1.5.2. Company Financials
15.1.5.3. Growth Strategies
15.1.5.4. SWOT Analysis
15.1.6. Ancestry
15.1.6.1. Company Overview
15.1.6.2. Company Financials
15.1.6.3. Growth Strategies
15.1.6.4. SWOT Analysis
15.1.7. MyMedLab, Inc.
15.1.7.1. Company Overview
15.1.7.2. Company Financials
15.1.7.3. Growth Strategies
15.1.7.4. SWOT Analysis
15.1.8. WellnessFX
15.1.8.1. Company Overview
15.1.8.2. Company Financials
15.1.8.3. Growth Strategies
15.1.8.4. SWOT Analysis
15.1.9. ANY LAB TEST NOW
15.1.9.1. Company Overview
15.1.9.2. Company Financials
15.1.9.3. Growth Strategies
15.1.9.4. SWOT Analysis
15.1.10. LetsGetChecked
15.1.10.1. Company Overview
15.1.10.2. Company Financials
15.1.10.3. Growth Strategies
15.1.10.4. SWOT Analysis
15.1.11. Color Genomics
15.1.11.1. Company Overview
15.1.11.2. Company Financials
15.1.11.3. Growth Strategies
15.1.11.4. SWOT Analysis
Table 01: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 02: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 03: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk assessment testing, 2017–2031
Table 04: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 08: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 09: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 10: North America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 18: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 19: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 20: Asia Pacific Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 23: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 24: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 25: Latin America Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031
Table 28: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 29: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031
Table 30: Middle East & Africa Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031